Hybridoma clone 2G9C3 kit
Company
Bayer Corporation
Use
In vivo or in vitro use for detecting or treating human cancer
Features
Engineered to produce a desired antibody in large anounts
NIH Contribution
Developed hybridoma clone 2G9C3
HHS Institute/Agency
NCI
Inventor(s)
L. Varesio, S. Giardina, D. Longo
Year
1994
Tech Cat
Research Reagent
![L-043-1989 L-043-1989](/sites/default/files/styles/large/public/images/showcase/29281/generic-antibody-picture-4149.jpg?itok=Qe0AtJUH)